Figure 5From: The emergence of commercial genomics: analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004Employment trends. Top 15 genomics firms by market capitalization are: Applera, Millennuim Pharmaceuticals, Invitrogen, OSI Pharmaceuticals, Gen-Probe, Affymetrix, Protein Design Labs, Human Genome Sciences, ZymoGenetics, Abgenix, Incyte, Digene, Exelixis Pharmaceuticals, Lexicon Genetics, and Rigel Pharmaceuticals.Back to article page